Reality check for pemetrexed and maintenance therapy in advanced non-small-cell lung cancer

Affiliations

Comment

Nevin Murray. J Clin Oncol. 2014.

. 2014 Feb 10;32(5):482-3.

doi: 10.1200/JCO.2013.53.3448. Epub 2014 Jan 6.

¹ University of British Columbia and British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

No abstract available

Comment in

Reply to S. Barni et Al, K.R. Dearing et al, and N. Murray.
Paz-Ares LG, de Marinis F, Visseren-Grul C, Gridelli C. Paz-Ares LG, et al. J Clin Oncol. 2014 Feb 10;32(5):483-5. doi: 10.1200/JCO.2013.53.6011. Epub 2014 Jan 6. J Clin Oncol. 2014. PMID: 24395851 No abstract available.

PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.
Paz-Ares LG, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C. Paz-Ares LG, et al. J Clin Oncol. 2013 Aug 10;31(23):2895-902. doi: 10.1200/JCO.2012.47.1102. Epub 2013 Jul 8. J Clin Oncol. 2013. PMID: 23835707 Clinical Trial.